We are live on
!
Find out more
CA
Cullinan Associates Portfolio holdings
AUM
$1.24B
1-Year Est. Return
28.12%
This Fund
S&P 500
This Quarter
Est. Return
-0.44%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.41B
AUM Growth
-$143M
(-9.2%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-7.65%
Top 10 Holdings %
Top 10 Hldgs %
40.58%
Holding
226
New
9
Increased
48
Reduced
78
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Company
SO
|
+$3.36M |
| 2 |
Procore
PCOR
|
+$1.51M |
| 3 |
TJX Companies
TJX
|
+$1.37M |
| 4 |
Home Depot
HD
|
+$1.2M |
| 5 |
HP
HPQ
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$45.4M |
| 2 |
Walmart Inc
WMT
|
+$20.5M |
| 3 |
West Pharmaceutical
WST
|
+$9.83M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$5.45M |
| 5 |
Tesla
TSLA
|
+$4.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.07% |
| 2 | Financials | 17.13% |
| 3 | Consumer Staples | 16.22% |
| 4 | Healthcare | 10.07% |
| 5 | Consumer Discretionary | 7.96% |
Similar funds
WTA
QI
MP
GX
HCA
NHAS
CCA
XF
Cullinan Associates's Q1 2025 Portfolio in Review
As of Q1 2025, Cullinan Associates held 226 positions worth $1.41B, down 9.2% from $1.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Cullinan Associates withdrew a net $108M in Q1 2025, closing 10 positions and reducing 78 holdings. Its most notable exit was West Pharmaceutical, an estimated $9.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Cullinan Associates opened a new position in Procore worth $1.32M.
- Cullinan Associates's largest Q1 2025 buy was Procore: 20,000 shares worth $1.32M.
- Cullinan Associates added most to Southern Company in Q1 2025, an estimated $3.36M increase.
- Cullinan Associates's biggest Q1 2025 reduction was Apple, cutting an estimated $45.4M.
- Cullinan Associates fully exited West Pharmaceutical in Q1 2025, selling an estimated $9.83M.
- Cullinan Associates's ten largest holdings make up 41% of its $1.41B portfolio in Q1 2025.
- Cullinan Associates opened 9 new positions and closed 10 in Q1 2025.
- Cullinan Associates's portfolio value fell 9.2% quarter-over-quarter to $1.41B.
Based on Cullinan Associates's 13F filing for Q1 2025, filed 22 Apr 2025.